Statistics for Xlife Sciences AG (id:13147 XLS)

Valuation metrics

Market cap

164.21M

Enterprise value

312.62M

Trailing P/E (ttm)

8.77

Forward P/E

-44.69

PEG ratio

-44.69

Price/Sales (ttm)

165.83

Price/Book (mrq)

0.60

Enterprise Value/Revenue

315.69

Enterprise Value/EBITDA

-113.95

Overview

Shares outstanding

5.74M

Float

2.87M

Shares short

% Held by insiders

0.50%

% Held by institutions

0.02%

Average volume (10 days)

4.78K

Average volume (90 days)

Price summary

52-Week low

22.50

52-Week high

51.40

52-Week change

-38.06%

Beta

0.55

50-Day moving average

27.42

200-Day moving average

34.06

Dividends and splits

Forward annual dividend rate

0.02

Forward annual dividend yield

0.00

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

September 22th, 2022

Last split factor

2:1

Last split date

May 03th, 2016

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

2.14K%

Operating margin

-2,664.30%

Operational effectiveness

Return on assets

-2.36%

Return on equity

4.47%

Income statement

Revenue (ttm)

0.18

Revenue per share (ttm)

0.18

Quarterly revenue growth (yoy)

Gross profit (ttm)

449.02K

EBITDA

-2,743,424.00

Net income to common (ttm)

21.24M

Diluted EPS (ttm)

3.26

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

99.78K

Total cash per share (mrq)

0.02

Total debt (mrq)

55.45M

Total Debt/Equity (mrq)

15.11

Current ratio (mrq)

269.80%

Book value per share (mrq)

47.84

Cash flow

Cash flow statement

1.91M

Levered free cash flow (LFCF)

-9,733,508.00